- Home
- AHG vs SMTI Comparison
AHG vs SMTI Comparison
Compare AHG & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AHG
- SMTI
- Stock Information
- Founded
- AHG 2013
- SMTI 1982
- Country
- AHG China
- SMTI United States
- Employees
- AHG N/A
- SMTI 108
- Industry
- AHG Business Services
- SMTI Medical/Dental Instruments
- Sector
- AHG Consumer Discretionary
- SMTI Health Care
- Exchange
- AHG Nasdaq
- SMTI Nasdaq
- Market Cap
- AHG 240.9M
- SMTI 288.2M
- IPO Year
- AHG N/A
- SMTI N/A
- Fundamental
- Price
- AHG $1.05
- SMTI $32.50
- Analyst Decision
- AHG
- SMTI Buy
- Analyst Count
- AHG 0
- SMTI 1
- Target Price
- AHG N/A
- SMTI $44.00
- AVG Volume (30 Days)
- AHG 11.9K
- SMTI 29.0K
- Earning Date
- AHG 10-25-2024
- SMTI 11-11-2024
- Dividend Yield
- AHG N/A
- SMTI N/A
- EPS Growth
- AHG N/A
- SMTI N/A
- EPS
- AHG N/A
- SMTI N/A
- Revenue
- AHG $2,414,338.00
- SMTI $72,410,222.00
- Revenue This Year
- AHG N/A
- SMTI $26.97
- Revenue Next Year
- AHG N/A
- SMTI $18.91
- P/E Ratio
- AHG N/A
- SMTI N/A
- Revenue Growth
- AHG N/A
- SMTI 21.42
- 52 Week Low
- AHG $0.53
- SMTI $26.00
- 52 Week High
- AHG $2.90
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- AHG 47.47
- SMTI 56.84
- Support Level
- AHG $1.04
- SMTI $30.29
- Resistance Level
- AHG $1.30
- SMTI $32.51
- Average True Range (ATR)
- AHG 0.10
- SMTI 1.60
- MACD
- AHG -0.01
- SMTI 0.31
- Stochastic Oscillator
- AHG 17.00
- SMTI 100.00
About AHG Akso Health Group ADS
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.